OUTCOMES OF THE SELF-INJECTION ASSESSMENT QUESTIONNAIRE IN RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS PATIENTS RECEIVING GP2015 (ETANERCEPT BIOSIMILAR) IN A REAL-WORLD STUDY: FINAL RESULTS FROM COMPACT STUDY

被引：0
|
作者：
Schmalzing, M. [1 ]
Askari, A. [2 ]
Sheeran, T. [3 ]
Jathanakodi, S. [4 ]
Both, C. [4 ]
Kellner, H. [5 ]
机构：
[1] Wuerzburg, Univ Hosp, Dept Internal Med 2, Rheumatol Clin Immunol, Wurzburg, Germany
[2] Robert Jones & Agnes Hunt Orthoped Hosp NHS Fdn T, Rheumatol, Oswestry, Shrops, England
[3] Univ Wolverhampton, New Cross & Cannock Chase Hosp, Dept Rheumatol, Wolverhampton, England
[4] Sandoz Hexal AG, Rheumatol, Holzkirchen, Germany
[5] Hosp Neuwittelsbach, Ctr Rheumatol & Gastroenterol, Munich, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Rheumatoid arthritis; Spondyloarthritis; Patient reported outcomes;
D O I：
10.1136/annrheumdis-2023-eular.442
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0419
引用
收藏
页码：1397 / 1397
页数：1
相关论文
共 50 条
  • [1] REAL-WORLD ASSESSMENT OF GP2015 (ETANERCEPT BIOSIMILAR, SDZ-ETN): AN INTERIM ANALYSIS OF DATA FROM THE SELF-INJECTION ASSESSMENT QUESTIONNAIRE IN PATIENTS WITH RHEUMATOID ARTHRITIS IN THE COMPACT STUDY
    Kellner, H.
    Askari, A.
    Kupka, T.
    Friccius-Quecke, H.
    Furlan, F.
    Hachaichi, S.
    Schmalzing, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1445 - 1445
  • [2] Real-World Drug Persistence of GP2015, an Etanercept Biosimilar, in Patients with Rheumatoid Arthritis: Results from the Multi-Country COMPACT Study
    Schmalzing, Marc
    Both, Charlotte
    Brueckmann, Ines
    de Toro Santos, Javier
    Sheeran, Tom
    Kellner, Herbert
    Askari, Ayman
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4296 - 4298
  • [3] EFFECTIVENESS AND SAFETY OF BIOSIMILAR ETANERCEPT GP2015 IN PATIENTS WITH RHEUMATOID ARTHRITIS IN THE UK: RESULTS FROM THE COMPACT STUDY
    Askari, Ayman
    Both, Charlotte
    Martin, Angela
    Walsh, David A.
    Sheeran, Tom
    RHEUMATOLOGY, 2024, 63 : I81 - I81
  • [4] Effectiveness and safety of biosimilar etanercept GP2015 in patients with rheumatoid arthritis in the UK: results from the COMPACT study
    Askari, Ayman
    Both, Charlotte
    Martin, Angela
    Walsh, David A.
    Sheeran, Tom
    RHEUMATOLOGY, 2024, 63
  • [5] Real-world effectiveness and persistence of reference etanercept versus biosimilar etanercept GP2015 among rheumatoid arthritis patients: A cohort study
    Carballo, Nuria
    Perez Garcia, Carolina
    Grau, Santiago
    Monfort, Jordi
    Duran-Jorda, Xavier
    Echeverria-Esnal, Daniel
    Ferrandez, Olivia
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [6] REAL-WORLD EFFECTIVENESS AND SAFETY OF GP2015 IN PATIENTS WITH RHEUMATIC DISEASES: FINAL RESULTS OF THE COMPACT STUDY
    Schmalzing, M.
    Kellner, H.
    Askari, A.
    Santos, J. De Toro
    Vazquez Perez-Coleman, J. C.
    Foti, R.
    Jeka, S.
    Haraoui, B.
    Allanore, Y.
    Rahman, M.
    Furlan, F.
    Hachaichi, S.
    Sheeran, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 589 - 590
  • [7] Real-World Evidence for GP2015 in Patients with Rheumatoid Arthritis: Safety Outcomes from German Observational Data
    Baraliakos, Xenofon
    Salvati, Cristofer
    Bachinskaya, Elena
    Sinha, Samriddhi
    Krueger, Klaus
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1030 - 1032
  • [8] Effectiveness of GP2015 in biologic-naive patients with early rheumatoid arthritis: Results from the COMPACT Study
    Schmalzing, M.
    Askari, A.
    Jeka, S.
    de Toro, J.
    Jathanakodi, S.
    Both, C.
    Kellner, H.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2023, 52 : 61 - 62
  • [9] Patient-reported Outcomes and Quality of Life in Patients with Rheumatoid Arthritis Treated with GP2015: Final Results from a Realworld Study
    Askari, Ayman
    Schmalzing, Marc
    Kellner, Herbert
    Ortega-Castro, Rafaela
    Perez-Coleman, Julio Cesar Vazquez
    Rosario, Foti
    Jeka, Slawomir
    Haraoui, Boulos
    Allanore, Yannick
    Rahman, Masiur
    Furlan, Fabricio
    Hachaichi, Sohaib
    Sheeran, Tom
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 353 - 354
  • [10] Etanercept Biosimilar GP2015 Has Equivalent Efficacy and Safety to Etanercept Originator in Patients with Moderate to Severe Rheumatoid Arthritis: The Phase 3 Equira Study
    Kavanaugh, Arthur
    Allanore, Yannick
    Kucharz, Eugeniusz J.
    Babic, Goran
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
12345